Pricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research highlights the various issues affecting the pricing and reimbursement environment for generics in Europe. It includes an overview of the generics market, key trends, country-wise market trends, list of market participants, strategic suggestions and decision support databases.

Table of Contents

Pricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe , Executive SummaryExecutive SummaryExecutive SummaryPricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe , Glossary of TermsImportant TermsDefinitionsPricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe , Research MethodologyMethodology Of ResearchThe "12 Step" Market Engineering Research Methodology and ProcessPricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe , IntroductionOverviewMarket AnalysisScope and ObjectivesPricing and ReimbursementThe Biosimilars OpportunityPricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe , Key TrendsPharmaceutical Cost-containment MeasuresReference PricingParallel TradeGeneric SubstitutionPatient Co-payments and ReimbursementPolitical/Legal/Regulatory IssuesImpact of EU AccessionThe Roche/Bolar ProvisionData Exclusivity and Marketing Authorisation ApplicationsPricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe , Country-wise Policy AnalysisGroup IDenmarkGermanyThe NetherlandsThe United KingdomGroup IIAustriaBelgiumFranceItalyPortugalSpainGroup IIICentral and Eastern Europe (CEE)Pricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe , Market ParticipantsMarket PlayersList of Generics Market ParticipantsList of Biosimilars Market ParticipantsPricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe , Strategic RecommendationsRecommendations to Market ParticipantsStrategic SuggestionsPricing and Reimbursement Issues for Generics & Biosimilars Markets in Europe , Decision Support DatabasesDSDsTotal Healthcare ExpenditurePharma R&D Expenditure




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.